- Home
- TLSI vs RMBI Comparison
TLSI vs RMBI Comparison
Compare TLSI & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- RMBI
- Stock Information
- Founded
- TLSI 2010
- RMBI 1887
- Country
- TLSI United States
- RMBI United States
- Employees
- TLSI N/A
- RMBI N/A
- Industry
- TLSI Medical Specialities
- RMBI Major Banks
- Sector
- TLSI Health Care
- RMBI Finance
- Exchange
- TLSI Nasdaq
- RMBI Nasdaq
- Market Cap
- TLSI 160.4M
- RMBI 139.1M
- IPO Year
- TLSI N/A
- RMBI 2019
- Fundamental
- Price
- TLSI $5.21
- RMBI $13.04
- Analyst Decision
- TLSI Strong Buy
- RMBI
- Analyst Count
- TLSI 5
- RMBI 0
- Target Price
- TLSI $10.90
- RMBI N/A
- AVG Volume (30 Days)
- TLSI 41.1K
- RMBI 31.6K
- Earning Date
- TLSI 05-15-2025
- RMBI 07-24-2025
- Dividend Yield
- TLSI N/A
- RMBI 4.49%
- EPS Growth
- TLSI N/A
- RMBI 2.54
- EPS
- TLSI N/A
- RMBI 0.89
- Revenue
- TLSI $32,141,000.00
- RMBI $42,825,687.00
- Revenue This Year
- TLSI $55.13
- RMBI N/A
- Revenue Next Year
- TLSI $50.71
- RMBI N/A
- P/E Ratio
- TLSI N/A
- RMBI $14.87
- Revenue Growth
- TLSI 46.20
- RMBI 2.64
- 52 Week Low
- TLSI $3.50
- RMBI $11.21
- 52 Week High
- TLSI $7.55
- RMBI $15.15
- Technical
- Relative Strength Index (RSI)
- TLSI 46.54
- RMBI 38.39
- Support Level
- TLSI $4.95
- RMBI $13.30
- Resistance Level
- TLSI $5.68
- RMBI $13.75
- Average True Range (ATR)
- TLSI 0.40
- RMBI 0.45
- MACD
- TLSI 0.01
- RMBI -0.17
- Stochastic Oscillator
- TLSI 39.74
- RMBI 2.38
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.